FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders

被引:0
|
作者
Sandrine Hayette
Mylène Gadoux
Sylvie Martel
Suzanne Bertrand
Isabelle Tigaud
Jean-Pierre Magaud
Ruth Rimokh
机构
[1] Laboratoire de Cytogénétique Moléculaire,
[2] Hopital Edouard Herriot,undefined
[3] Unité lNSERM U453,undefined
[4] Centre Léon Bérard,undefined
来源
Oncogene | 1998年 / 16卷
关键词
FLRG; follistatin; chromosomal translocation; carcinogenesis;
D O I
暂无
中图分类号
学科分类号
摘要
We report here the molecular study of a t(11;19)(q13;p13) translocation observed in a case of B-cell chronic lymphocytic leukemia. This translocation leads to the juxtaposition of the CCND1 gene on chromosome 11 to a new transcriptionnal unit on chromosome 19. The cDNA of this new evolutionarily conserved gene (named FLRG for Follistatin-Related Gene) codes for a secreted glycoprotein of the follistatin-module-protein family. FLRG is expressed in a wide range of human and murine adult tissues and its expression seems to be tightly regulated during murine embryogenesis. Its transcripts could not be detected in hematopoietic cells from all lineages and in particular in cells from lymphoid B and T lineage except in the t(11;19)-carrying leukemia described here. A great variability of expression is observed among the other tumoral cell lines analysed. Besides the t(11;19)-carrying leukemia described in this work, structural rearrangements of the FLRG locus have been found in a non-Hodgkin lymphoma, suggesting that it may play a role in leukemogenesis.
引用
收藏
页码:2949 / 2954
页数:5
相关论文
共 50 条
  • [31] RET gene rearrangement: a potential new target in lung cancer treatment
    Spray, Nicole
    PERSONALIZED MEDICINE, 2013, 10 (06) : 528 - 529
  • [32] RET gene rearrangement: a potential new target in lung cancer treatment
    Spray, Nicole
    LUNG CANCER MANAGEMENT, 2013, 2 (04) : 257 - 257
  • [33] Impact of fetal chromosomal disorders on maternal blood metabolome: toward new biomarkers?
    Pinto, Joana
    Almeida, Lara Monteiro
    Martins, Ana Sofia
    Duarte, Daniela
    Marques Domingues, Maria Rosario
    Barros, Antonio Sousa
    Galhano, Eulalia
    Pita, Cristina
    Almeida, Maria do Ceu
    Carreira, Isabel Marques
    Gil, Ana Maria
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 213 (06) : 841.e1 - 841.e15
  • [34] EXPRESSION OF A MULTIDRUG-RESISTANCE GENE IN HUMAN-MALIGNANT LYMPHOMA AND RELATED DISORDERS
    DAN, S
    ESUMI, M
    SAWADA, U
    HAYASHI, N
    UCHIDA, T
    YAMAZAKI, T
    ASHIYA, M
    SATOH, Y
    OHSHIM, T
    HORIE, T
    TSURUO, T
    SHIKATA, T
    LEUKEMIA RESEARCH, 1991, 15 (12) : 1139 - 1143
  • [35] GPR75: An exciting new target in metabolic syndrome and related disorders
    Murtaza, Babar
    Asghar, Faiza
    Patoli, Danish
    BIOCHIMIE, 2022, 195 : 19 - 26
  • [37] Gene expression profiling of blood in subjects with Duchenne muscular dystrophy and related disorders
    Wong, B.
    Gilbert, D.
    Walker, W.
    Liao, I.
    Xu, H.
    Gregg, J.
    Apperson, M.
    Sharp, F.
    NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 842 - 842
  • [38] Tumor suppressor MCPH1 regulates gene expression profiles related to malignant conversion and chromosomal assembly
    Tervasmaki, Anna
    Mantere, Tuomo
    Eshraghi, Leila
    Laurila, Niina
    Tuppurainen, Hanna
    Ronkainen, Veli-Pekka
    Koivuluoma, Susanna
    Devarajan, Raman
    Peltoketo, Hellevi
    Pylkas, Katri
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (08) : 2070 - 2081
  • [39] Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
    Russo, Andrew F.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55, 2015, 55 : 533 - 552
  • [40] Synaptic Plasticity as a Therapeutic Target in the Treatment of Autism-related Single-gene Disorders
    Pignatelli, Marco
    Feligioni, Marco
    Piccinin, Sonia
    Molinaro, Gemma
    Nicoletti, Ferdinando
    Nistico, Robert
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (36) : 6480 - 6490